The Standards & Best Practices Committee provides best practices and recommendations for standard pharmacometric analyses (e.g. population PK/PD, exposure-response, disease models) with the goal to increase consistency, productivity, quality, communication, and impact of pharmacometrics on decision making. In the future, we anticipate expanding to cover QSP as well.
- Our commentary on drug-drug interactions has been published!
The Committee’s activities are concentrated into two main workstreams.
Model Evaluation Working Group (“MoEv”)
The Model Evaluation Working Group (“MoEv”) is tasked with producing a series of model evaluation tutorials for publication in the peer-reviewed literature. So far, three have been planned; of these, one is accepted, one is undergoing internal review, and one is in active development.
- The first MoEv tutorial has been published!
Data Standards Working Group
The Data Standards Working Group is developing a set of standards for population PK datasets, which we ultimately hope will be folded into the CDISC standard, and investigating ways to improve the provenance of source data.
- A first summary of the Data Standards Survey has been released!
Do you have any ideas for our Committee? Want to join one of the above activities? Contact us!